{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T17:38:48Z","timestamp":1788889128350,"version":"build-2803163510"},"reference-count":27,"publisher":"Oxford University Press (OUP)","issue":"8","license":[{"start":{"date-parts":[[2019,2,13]],"date-time":"2019-02-13T00:00:00Z","timestamp":1550016000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Blue Cross and Blue Shield of Michigan and Blue Care Network"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,9,27]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Fluoroquinolones increase the risk of Clostridioides difficile infection and antibiotic resistance. Hospitals often use pre-prescription approval or prospective audit and feedback to target fluoroquinolone prescribing. Whether these strategies impact aggregate fluoroquinolone use is unknown.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>This study is a 48-hospital, retrospective cohort of general-care, medical patients hospitalized with pneumonia or positive urine culture between December 2015\u2013September 2017. Hospitals were surveyed on their use of pre-prescription approval and\/or prospective audit and feedback to target fluoroquinolone prescribing during hospitalization (fluoroquinolone stewardship). After controlling for hospital clustering and patient factors, aggregate (inpatient and post-discharge) fluoroquinolone (ciprofloxacin, levofloxacin, moxifloxacin) exposure was compared between hospitals with and without fluoroquinolone stewardship.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>There were 11 748 patients (6820 pneumonia; 4928 positive urine culture) included at 48 hospitals. All hospitals responded to the survey: 29.2% (14\/48) reported using pre-prescription approval and\/or prospective audit and feedback to target fluoroquinolone prescribing. After adjustment, fluoroquinolone stewardship was associated with fewer patients receiving a fluoroquinolone (37.1% vs 48.2%; P = .01) and fewer fluoroquinolone treatment days per 1000 patients (2282 vs 3096 days\/1000 patients; P = .01), driven by lower inpatient prescribing. However, most (66.6%) fluoroquinolone treatment days occurred after discharge, and hospitals with fluoroquinolone stewardship had twice as many new fluoroquinolone starts after discharge as hospitals without (15.6% vs 8.4%; P = .003).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Hospital-based stewardship interventions targeting fluoroquinolone prescribing were associated with less fluoroquinolone prescribing during hospitalization, but not at discharge. To limit aggregate fluoroquinolone exposure, stewardship programs should target both inpatient and discharge prescribing.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/cid\/ciy1102","type":"journal-article","created":{"date-parts":[[2018,12,20]],"date-time":"2018-12-20T20:15:15Z","timestamp":1545336915000},"page":"1269-1277","source":"Crossref","is-referenced-by-count":59,"title":["The Association of Antibiotic Stewardship With Fluoroquinolone Prescribing in Michigan Hospitals: A Multi-hospital Cohort Study"],"prefix":"10.1093","volume":"69","author":[{"given":"Valerie M","family":"Vaughn","sequence":"first","affiliation":[{"name":"Division of Hospital Medicine, Department of Internal Medicine, Michigan Medicine, Ann Arbor, Michigan"},{"name":"Center for Clinical Management Research, Veterans Affairs Ann Arbor Health System, Ann Arbor, Michigan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tejal","family":"Gandhi","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Department of Internal Medicine, Michigan Medicine, Ann Arbor, Michigan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Conlon","sequence":"additional","affiliation":[{"name":"Division of Hospital Medicine, Department of Internal Medicine, Michigan Medicine, Ann Arbor, Michigan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vineet","family":"Chopra","sequence":"additional","affiliation":[{"name":"Division of Hospital Medicine, Department of Internal Medicine, Michigan Medicine, Ann Arbor, Michigan"},{"name":"Center for Clinical Management Research, Veterans Affairs Ann Arbor Health System, Ann Arbor, Michigan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anurag N","family":"Malani","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Department of Internal Medicine, St. Joseph Mercy Health System, Ann Arbor, Michigan"},{"name":"Department of Infection Prevention and Control, St. Joseph Mercy Health System, Ann Arbor, Michigan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott A","family":"Flanders","sequence":"additional","affiliation":[{"name":"Division of Hospital Medicine, Department of Internal Medicine, Michigan Medicine, Ann Arbor, Michigan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2019,2,13]]},"reference":[{"key":"2019092701021583400_CIT0001","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1001\/jama.2014.12923","article-title":"Prevalence of antimicrobial use in US acute care hospitals, May-September 2011","volume":"312","author":"Magill","year":"2014","journal-title":"JAMA"},{"key":"2019092701021583400_CIT0002","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1001\/jamainternmed.2017.1938","article-title":"Association of adverse events with antibiotic use in hospitalized patients","volume":"177","author":"Tamma","year":"2017","journal-title":"JAMA Intern Med"},{"key":"2019092701021583400_CIT0003","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1086\/496986","article-title":"Emergence of fluoroquinolones as the predominant risk factor for Clostridium difficile-associated diarrhea: a cohort study during an epidemic in Quebec","volume":"41","author":"P\u00e9pin","year":"2005","journal-title":"Clin Infect Dis"},{"key":"2019092701021583400_CIT0004","doi-asserted-by":"crossref","first-page":"e51","DOI":"10.1093\/cid\/ciw118","article-title":"Implementing an antibiotic stewardship program: guidelines by the Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America","volume":"62","author":"Barlam","year":"2016","journal-title":"Clin Infect Dis"},{"key":"2019092701021583400_CIT0005","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/S1473-3099(16)30514-X","article-title":"Effects of control interventions on Clostridium difficile infection in England: an observational study","volume":"17","author":"Dingle","year":"2017","journal-title":"Lancet Infect Dis"},{"key":"2019092701021583400_CIT0006","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1186\/1471-2334-11-187","article-title":"Unnecessary use of fluoroquinolone antibiotics in hospitalized patients","volume":"11","author":"Werner","year":"2011","journal-title":"BMC Infect Dis"},{"key":"2019092701021583400_CIT0007","first-page":"CD003: 1465\u20131858","article-title":"Interventions to improve antibiotic prescribing practices for hospital inpatients","volume":"2","author":"Davey","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"2019092701021583400_CIT0008","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1086\/677624","article-title":"Comparison of prior authorization and prospective audit with feedback for antimicrobial stewardship","volume":"35","author":"Mehta","year":"2014","journal-title":"Infect Control Hosp Epidemiol"},{"key":"2019092701021583400_CIT0009","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.jhin.2015.05.013","article-title":"Effects of fluoroquinolone restriction (from 2007 to 2012) on Clostridium difficile infections: interrupted time-series analysis","volume":"91","author":"Sarma","year":"2015","journal-title":"J Hosp Infect"},{"key":"2019092701021583400_CIT0010","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1093\/cid\/ciy155","article-title":"Impact of implementing antibiotic stewardship programs in 15 small hospitals: a cluster-randomized intervention","volume":"67","author":"Stenehjem","year":"2018","journal-title":"Clin Infect Dis"},{"key":"2019092701021583400_CIT0011","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s11908-018-0615-z","article-title":"Fluoroquinolone restriction as an effective antimicrobial stewardship intervention","volume":"20","author":"Claeys","year":"2018","journal-title":"Curr Infect Dis Rep"},{"key":"2019092701021583400_CIT0012","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.annepidem.2013.02.005","article-title":"Accuracy of ICD-9-CM codes in identifying infections of pneumonia and herpes simplex virus in administrative data","volume":"23","author":"Drahos","year":"2013","journal-title":"Ann Epidemiol"},{"key":"2019092701021583400_CIT0013","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1164\/rccm.200405-644ST","article-title":"Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia","volume":"171","year":"2005","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"key":"2019092701021583400_CIT0014","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1177\/1077558715616028","article-title":"Getting to zero: goal commitment to reduce blood stream infections","volume":"73","author":"McAlearney","year":"2016","journal-title":"Med Care Res Rev"},{"key":"2019092701021583400_CIT0015","first-page":"20","article-title":"Multiple imputations in sample surveys-a phenomenological Bayesian approach to nonresponse.","volume-title":"Program and abstracts of the American Statistical Association (San Diego, CA). Alexandria, VA: American Statistical Association","author":"Rubin","year":"1978"},{"key":"2019092701021583400_CIT0016","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1186\/1471-2334-14-201","article-title":"Feasibility and impact of an intensified antibiotic stewardship programme targeting cephalosporin and fluoroquinolone use in a tertiary care university medical center","volume":"14","author":"Borde","year":"2014","journal-title":"BMC Infect Dis"},{"key":"2019092701021583400_CIT0017","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1471-2334-14-13","article-title":"A systematic review and meta-analysis of the effects of antibiotic consumption on antibiotic resistance","volume":"14","author":"Bell","year":"2014","journal-title":"BMC Infect Dis"},{"key":"2019092701021583400_CIT0018","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1001\/jamainternmed.2015.1878","article-title":"Effectiveness of an antimicrobial stewardship approach for urinary catheter-associated asymptomatic bacteriuria","volume":"175","author":"Trautner","year":"2015","journal-title":"JAMA Intern Med"},{"key":"2019092701021583400_CIT0019","author":"FDA Drug Safety Communication."},{"key":"2019092701021583400_CIT0020","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1086\/513535","article-title":"Evaluation of antimicrobial therapy orders circumventing an antimicrobial stewardship program: investigating the strategy of \u201cstealth dosing.\u201d","volume":"28","author":"LaRosa","year":"2007","journal-title":"Infect Control Hosp Epidemiol"},{"key":"2019092701021583400_CIT0021","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1002\/jhm.2648","article-title":"Total duration of antimicrobial therapy in veterans hospitalized with uncomplicated pneumonia: Results of a national medication utilization evaluation","volume":"11","author":"Madaras-Kelly","year":"2016","journal-title":"J Hosp Med"},{"key":"2019092701021583400_CIT0022","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1017\/ice.2017.10","article-title":"Intervention to reduce broad-spectrum antibiotics and treatment durations prescribed at the time of hospital discharge: a novel stewardship approach","volume":"38","author":"Yogo","year":"2017","journal-title":"Infect Control Hosp Epidemiol"},{"key":"2019092701021583400_CIT0023","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1093\/cid\/cit710","article-title":"Implementing a strategy for monitoring inpatient antimicrobial use among hospitals in the United States","volume":"58","author":"Fridkin","year":"2014","journal-title":"Clin Infect Dis"},{"key":"2019092701021583400_CIT0024","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1093\/cid\/ciw787","article-title":"Expert consensus on metrics to assess the impact of patient-level antimicrobial stewardship interventions in acute-care settings","volume":"64","author":"Moehring","year":"2017","journal-title":"Clin Infect Dis"},{"key":"2019092701021583400_CIT0025","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1001\/archinte.164.5.538","article-title":"Trends in postdischarge mortality and readmissions: has length of stay declined too far?","volume":"164","author":"Baker","year":"2004","journal-title":"Arch Intern Med"},{"key":"2019092701021583400_CIT0026","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1017\/ice.2016.57","article-title":"Audit and feedback processes among antimicrobial stewardship programs: a survey of the society for healthcare epidemiology of America research network","volume":"37","author":"Livorsi","year":"2016","journal-title":"Infect Control Hosp Epidemiol"},{"key":"2019092701021583400_CIT0027","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1136\/bmjqs-2017-007578","article-title":"Thoughtless design of the electronic health record drives overuse, but purposeful design can nudge improved patient care","volume":"27","author":"Vaughn","year":"2018","journal-title":"BMJ Qual Saf"}],"container-title":["Clinical Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/cid\/article-pdf\/69\/8\/1269\/30063345\/ciy1102.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,27]],"date-time":"2019-09-27T05:03:31Z","timestamp":1569560611000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cid\/article\/69\/8\/1269\/5316467"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,13]]},"references-count":27,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2019,2,13]]},"published-print":{"date-parts":[[2019,9,27]]}},"URL":"https:\/\/doi.org\/10.1093\/cid\/ciy1102","relation":{},"ISSN":["1058-4838","1537-6591"],"issn-type":[{"value":"1058-4838","type":"print"},{"value":"1537-6591","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2019,10,15]]},"published":{"date-parts":[[2019,2,13]]}}}